We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Paracetamol During Pregnancy May Reduce Fertility of Daughters

By HospiMedica International staff writers
Posted on 25 Jan 2018
Taking the painkiller paracetamol (acetaminophen) during pregnancy may impair the future fertility of female offspring, according to a new review of studies.

Researchers at Rigshospitalet Glostrup (Denmark) and Institut de recherche en santé, environnement et travail (IRSET; Rennes, France) reviewed three rodent studies that evaluated the effect of acetaminophen (N-Acetyl-p-Aminophenol; APAP) taken during pregnancy on the development of the reproductive system in female offspring. More...
The rodents were given paracetamol during pregnancy at doses equivalent to those a pregnant woman may take for pain relief. The results collectively showed that prenatal exposure around 13.5 days post-coitum may result in reduced female reproductive health.

The combined data indicate that the exposure results in a reduction in primordial follicles, irregular cycling, premature absence of corpus luteum, and reduced fertility. According to the researchers, the overall combination of symptom resembles premature ovarian insufficiency syndrome in humans, which has been linked to premature menopause. They therefore recommend an inter-disciplinary approach that combines epidemiological data from human studies with more experimental research to firmly establish this link. The study was published on January 5, 2018, in Endocrine Connections.

“Although this may not be a severe impairment to fertility, it is still of real concern since data from three different labs all independently found that paracetamol may disrupt female reproductive development,” said lead author David Kristensen, MD, of Rigshospitalet, and colleagues. “As scientists, we are not in the position to make any medical recommendations, and we would urge pregnant women in pain to consult with their general practitioner, midwife or pharmacist for professional advice.”

Paracetamol, discovered in 1877, is classified as a mild analgesic, commonly used for relief of headaches and other minor aches and pains, and is a major ingredient in numerous cold and flu remedies. APAP use during pregnancy has previously been associated with an increased risk of childhood asthma and attention deficit hyperactivity disorder (ADHD), but it is unclear whether the relationship is causal. A similar study by the same researchers showed that paracetamol can inhibit androgens and prostaglandin action during male fetal development, resulting in reduced sex drive and aggressive behavior.

Related Links:
Rigshospitalet Glostrup


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Complete Hip System
Taperloc Complete Hip System
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.